{"bill":{"bill_id":1196655,"change_hash":"69f6374ebed1eaf5e4c0283d1e4ff558","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB417\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/417\/all-info","completed":0,"status":1,"status_date":"2019-02-07","progress":[{"date":"2019-02-07","event":1},{"date":"2019-02-07","event":9}],"state":"US","state_id":52,"bill_number":"SB417","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"Changing the Culture of the FDA Act","description":"Requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)","pending_committee_id":2328,"committee":{"committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"},"referrals":[{"date":"2019-02-07","committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"}],"history":[{"date":"2019-02-07","action":"Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9625,"person_hash":"7pac6cxl","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Joe Manchin","first_name":"Joe","middle_name":"","last_name":"Manchin","suffix":"III","nickname":"","district":"SD-WV","ftm_eid":7573477,"votesmart_id":7547,"opensecrets_id":"N00032838","knowwho_pid":219013,"ballotpedia":"Joe_Manchin_III","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13156,"subject_name":"Department of Health and Human Services"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13345,"subject_name":"Drug trafficking and controlled substances"},{"subject_id":13787,"subject_name":"Food and Drug Administration (FDA)"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":1937169,"date":"2019-02-27","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB417\/id\/1937169","state_link":"https:\/\/www.congress.gov\/116\/bills\/s417\/BILLS-116s417is.pdf","text_size":274371,"text_hash":"775ebced595ad406af3498a2b1248295"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}